rs36095561

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002547.3(OPHN1):​c.2079G>A​(p.Met693Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000705 in 1,199,775 control chromosomes in the GnomAD database, including 4 homozygotes. There are 210 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M693V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0036 ( 2 hom., 91 hem., cov: 22)
Exomes 𝑓: 0.00041 ( 2 hom. 119 hem. )

Consequence

OPHN1
NM_002547.3 missense

Scores

16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.00700

Publications

3 publications found
Variant links:
Genes affected
OPHN1 (HGNC:8148): (oligophrenin 1) This gene encodes a Rho-GTPase-activating protein that promotes GTP hydrolysis of Rho subfamily members. Rho proteins are important mediators of intracellular signal transduction, which affects cell migration and cell morphogenesis. Mutations in this gene are responsible for OPHN1-related X-linked cognitive disability with cerebellar hypoplasia and distinctive facial dysmorhphism. [provided by RefSeq, Jul 2008]
OPHN1 Gene-Disease associations (from GenCC):
  • X-linked intellectual disability-cerebellar hypoplasia syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025024414).
BP6
Variant X-68063933-C-T is Benign according to our data. Variant chrX-68063933-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 159475.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00361 (399/110494) while in subpopulation AFR AF = 0.0127 (386/30332). AF 95% confidence interval is 0.0117. There are 2 homozygotes in GnomAd4. There are 91 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OPHN1NM_002547.3 linkc.2079G>A p.Met693Ile missense_variant Exon 21 of 25 ENST00000355520.6 NP_002538.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OPHN1ENST00000355520.6 linkc.2079G>A p.Met693Ile missense_variant Exon 21 of 25 1 NM_002547.3 ENSP00000347710.5

Frequencies

GnomAD3 genomes
AF:
0.00361
AC:
399
AN:
110442
Hom.:
2
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0128
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00135
GnomAD2 exomes
AF:
0.00112
AC:
191
AN:
170737
AF XY:
0.000834
show subpopulations
Gnomad AFR exome
AF:
0.0139
Gnomad AMR exome
AF:
0.000424
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000131
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000410
AC:
447
AN:
1089281
Hom.:
2
Cov.:
31
AF XY:
0.000334
AC XY:
119
AN XY:
355889
show subpopulations
African (AFR)
AF:
0.0132
AC:
345
AN:
26221
American (AMR)
AF:
0.000607
AC:
21
AN:
34575
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18958
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30018
South Asian (SAS)
AF:
0.0000569
AC:
3
AN:
52686
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40279
Middle Eastern (MID)
AF:
0.00196
AC:
8
AN:
4075
European-Non Finnish (NFE)
AF:
0.0000251
AC:
21
AN:
836828
Other (OTH)
AF:
0.00107
AC:
49
AN:
45641
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
17
34
50
67
84
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00361
AC:
399
AN:
110494
Hom.:
2
Cov.:
22
AF XY:
0.00278
AC XY:
91
AN XY:
32722
show subpopulations
African (AFR)
AF:
0.0127
AC:
386
AN:
30332
American (AMR)
AF:
0.00105
AC:
11
AN:
10472
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2624
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3463
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2436
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6006
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
215
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
52762
Other (OTH)
AF:
0.00133
AC:
2
AN:
1501
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
15
31
46
62
77
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00262
Hom.:
34
Bravo
AF:
0.00433
ESP6500AA
AF:
0.0130
AC:
50
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00126
AC:
153

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
May 03, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 08, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jun 01, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

X-linked intellectual disability-cerebellar hypoplasia syndrome Benign:1
Sep 17, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

OPHN1-related disorder Benign:1
May 13, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.88
T
BayesDel_noAF
Benign
-1.0
CADD
Benign
4.7
DANN
Benign
0.78
DEOGEN2
Benign
0.060
T
FATHMM_MKL
Benign
0.023
N
LIST_S2
Benign
0.62
T
MetaRNN
Benign
0.0025
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N
PhyloP100
0.0070
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.30
N
REVEL
Benign
0.045
Sift
Benign
0.46
T
Sift4G
Benign
0.47
T
Polyphen
0.0
B
Vest4
0.16
MutPred
0.099
Gain of catalytic residue at M693 (P = 0.0267);
MVP
0.12
MPC
0.13
ClinPred
0.0017
T
GERP RS
1.2
Varity_R
0.081
gMVP
0.055
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs36095561; hg19: chrX-67283775; COSMIC: COSV106497346; API